MFDS — authorised 23 September 1997
- Marketing authorisation holder: HOSPIRA
- Status: likely_approved
🇰🇷 Corlopam in South Korea
MFDS authorised Corlopam on 23 September 1997
Marketing authorisation
Corlopam in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Corlopam approved in South Korea?
Yes. MFDS authorised it on 23 September 1997.
Who is the marketing authorisation holder for Corlopam in South Korea?
HOSPIRA holds the South Korean marketing authorisation.